Literature DB >> 6428755

Natural killer cell defects resulting from thermal injury.

M D Stein, D N Gamble, K D Klimpel, D N Herndon, G R Klimpel.   

Abstract

Peripheral blood mononuclear lymphocytes (PBL) from thermal injury patients were examined for their ability to mediate spontaneous (NK) cytotoxic activity against K562 tumor cells. NK cell numbers were quantitated in burn patients using the fluorescein isothiocyanate-conjugated monoclonal antibody Leu-7 and an Ortho cell sorter. NK activity of burn patients was only 30% of control levels. Thus, at a 50:1 effector:target cell ratio, burn patients' PBL gave a mean of 18% killing as compared to 60% killing mediated by control PBL (14 individuals). Pretreatment of PBL with interferon-gamma or interferon-alpha enhanced NK activity of normal PBL but had no effect on the NK activity of PBL from burn patients. The number of cells bearing antigen recognized by Leu-7 was variable in burn patients, with some patients having decreased (less than 5%), normal (8-10%), or elevated (20-40%) numbers of Leu-7 bearing PBL. No differences were observed in the total numbers of PBL in burn patients when compared to control individuals. These results indicate that NK activity does not correlate with the percentage of Leu-7 bearing cells present in PBL and that the inability of thermal injury patients to mediate normal NK function may contribute to their susceptibilities to viral infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428755     DOI: 10.1016/0008-8749(84)90412-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

1.  Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries.

Authors:  T Katakura; T Yoshida; M Kobayashi; D N Herndon; F Suzuki
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  The cellular immune response in thermal injured patients.

Authors:  M Braquet; P Lavaud; R Ducousso; T Trenque; J J N'Guyen; J Guilbaud; P Braquet
Journal:  Agents Actions       Date:  1986-01

3.  Rationale, design and performance of a clinical trial to investigate interferon-gamma (Imukin) in the prophylactic treatment of severe burns-related infections.

Authors:  J D Ioannovich; R D Hinzmann; G Deichsel; G G Steinmann
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

4.  Peripheral blood lymphocytes from thermal injury patients are defective in their ability to generate lymphokine-activated killer (LAK) cell activity.

Authors:  G R Klimpel; D H Herndon; M D Stein
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

5.  [Immune paralysis in acute pancreatitis--HLA-DR antigen expression on CD14+DR+ monocytes].

Authors:  A Richter; T Nebe; R Kattermann; M Trede
Journal:  Langenbecks Arch Chir       Date:  1996

6.  Early burn wound excision significantly reduces blood loss.

Authors:  M H Desai; D N Herndon; L Broemeling; R E Barrow; R J Nichols; R L Rutan
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

7.  Defective NK cell activity following thermal injury.

Authors:  G R Klimpel; D N Herndon; M Fons; T Albrecht; M T Asuncion; R Chin; M D Stein
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

8.  Reduction in HLA-DR, HLA-DQ and HLA-DP expression by Leu-M3+ cells from the peripheral blood of patients with thermal injury.

Authors:  R A Gibbons; O M Martinez; R C Lim; J K Horn; M R Garovoy
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

9.  Suppression of natural killer-cell function in humans following thermal and traumatic injury.

Authors:  B A Blazar; M L Rodrick; J B O'Mahony; J J Wood; P Q Bessey; D W Wilmore; J A Mannick
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

10.  Depressed natural killer cell function in thermally injured adults: successful in vivo and in vitro immunomodulation and the role of endotoxin.

Authors:  B S Bender; R A Winchurch; J N Thupari; J J Proust; W H Adler; A M Munster
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.